Pre-Operative Assessment and Optimisation of the Older Surgical Patient

Size: px
Start display at page:

Download "Pre-Operative Assessment and Optimisation of the Older Surgical Patient"

Transcription

1 Pre-Operative Assessment and Optimisation of the Older Surgical Patient Hypertension, arrhythmias, pacemakers and anticoagulant drugs in the surgical patient

2 Hypertension It s common Control rates are not great Major Risk for CVD Treatment is beneficial

3 Attributable Risk of Hypertension able Heart Failure Stroke Dementia AMI PVD Cataract IHD Percentage

4 Questions to Consider 1. Is diagnosis of hypertension bad for you? 2. Is elevated BP at the time of admission bad for you? 3. Is poorly controlled hypertension bad for you? 4. Does treatment make a difference?

5 Diagnosis is bad for you? Howell SJ et al. Br J Anaeth (2004)

6 Admission BP Little data Early studies no increase risk Lacked statistical power Used specific cut offs Howell et al Data mostly for SBP below 180 mmhg s Data suggest increased risk if SBP over 180 mmhg

7 Cardiovascular Lability Hypertensives greater BP lability periop Poor control, greater lability Impact uncertain Possible more intra-operative ischaemia Possible more arrhythmias Greater impact for protracted surgery

8 Treatment If SBP < 180 mmhg + no complications no reason to delay If > 180 mmhg possible benefits from delay continue antihypertensive medications Debate about ACE-Is Post-op Pain control important Restart ACE-I when euvoleamic

9 Arrhythmias Common peri-operatively (60-80%) Usually clinically insignificant Numerous pre-op predictors reported Most consistent for AF age 60 Sinus tachy & bradycardia common

10 Pre-op search for underlying co-morbidities Asymptomatic ventricular arrhythmias no increase in cardiac complications after non-cardiac surgery. no intervention required AF commonest supraventricular tachycardia Cause Rate v rhythm Antithrombotics Amiodarone associated with respiratory failure post-op Chronic bifascular block rarely progresses

11 Peri-op Treatments Correct precipitants Sinus tachy AF/Flutter No clear guidelines for Rx post non-cardiac surgery Heamodynamically stable? B-blockers better than digoxin AVNRT/AVRT Consider valsalva/ CSM adenosine

12 Pacemakers and AICDs Why was it put in? What type? Pacemaker dependent Get it tested Problems uncommon Problem is EMI

13 1. Is EMI likely? 2. Preoperative reprogramming or disabling special algorithms needed? 3. Suspend antitachyarrhythmia functions 4. Advising bipolar electrocautery /ultrasonic scalpel 5. Assuring availability temporary pacing/ defibrillation equipment 6. Evaluating possible effects of anaesthetic techniques Anaesthesiology Feb 2011

14

15 Anticoagulants Pre-op ALL patients last dose of warfarin 4 days pre-op antithrombin deficiency or antiphospholipid antibodies? low risk, intermediate risk, high risk or very high risk?

16 Low risk: Target INR unless VTE with: active cancer intermediate risk VTE within last 3 months - intermediate risk VTE within last 6 weeks - high risk: ideally avoid surgery, temporary IVC filter non valvular AF target INR unless: TIA/CVA within the last 3 months (ideally avoid surgery) - intermediate risk Intermediate risk: DVT/PE target INR but VTE 6-12 weeks ago Valvular AF (even if INR target ) TIA/CVA within the last 3 months (ideally avoid surgery) High risk: VTE within the last 6 weeks ideally avoid surgery, temporary IVC filter Any indication with target INR , unless mechanical cardiac valves very high risk Very high risk: Mechanical cardiac valves

17 Anticoagulants Pre-op ALL patients last dose of warfarin 4 days pre-op antithrombin deficiency or antiphospholipid antibodies? low risk, intermediate risk, high risk or very high risk? Low risk Pre-op: No alternative required Intermediate risk Pre-op: Enoxaparin 40 mg 9am (day -3, -2-1) Omit morning of surgery High risk Pre-op: Enoxaparin1.5mg/kg 9am (day -3, -2-1) Omit morning of surgery Very high risk Pre-op: Admit patient day -3. IV UFH when INR <2.0 Stop 4 hours pre-op Post-op: Enoxaparin 40 mg 6-12 hrs post-op Post-op: Enoxaparin 40 mg 6-12 hours post-op Post-op: Enoxaparin 1.5mg/kg 6 hours post-op Post-op: Restart IV UFH immediately post-op Continue till target INR TWO consecutive occ.

18 Re-starting oral anticoagulant If no excessive bleeding (and epidural catheter has been removed), ideally evening of surgery once oral intake established INR less than 1.5 loading dose: 1.5 x usual dose 3 days then usual dose If INR more than 1.5 seek advice Consider interactions Refer local anticoagulation clinic within 3 days of d/c: only one INR in range pre d/c within 5 days if 2 consecutive INR s in range

19 Conclusions Pre-op assessment opportunity for screening SBP < 180 mmhg not a independent risk Arrhythmia consider why Pacemakers consider fixed rate if EMI Anticoagulants establish clear SOPs Area needs further research

4.7 Algorithm for the Peri-operative Management of Anticoagulants and Antiplatelet agents in Adult patients

4.7 Algorithm for the Peri-operative Management of Anticoagulants and Antiplatelet agents in Adult patients 4.7 Algorithm for the Peri-operative Management of Anticoagulants and Antiplatelet agents in Adult patients Assess Thrombosis risk: baseline risk in an individual patient plus additional thrombotic risk

More information

2017 Bryan Health Primary Care Conference. Dale Hansen MD Bryan Heart 5/20/17

2017 Bryan Health Primary Care Conference. Dale Hansen MD Bryan Heart 5/20/17 2017 Bryan Health Primary Care Conference Dale Hansen MD Bryan Heart 5/20/17 I have no financial disclosures or conflicts of interest Bridging Anticoagulation Primum Non Nocere 67 y.o. male with mechanical

More information

Arrhythmias. A/Prof Drew Richardson. The Canberra Hospital May MB BS (Hons) FACEM Grad CertHE MD

Arrhythmias. A/Prof Drew Richardson. The Canberra Hospital May MB BS (Hons) FACEM Grad CertHE MD Arrhythmias A/Prof Drew Richardson MB BS (Hons) FACEM Grad CertHE MD The Canberra Hospital May 2013 Objectives Recognise the features of the common nonlethal arrhythmias Describe the emergency treatment

More information

ANTI-ARRHYTHMICS AND WARFARIN. Dr Nithish Jayakumar

ANTI-ARRHYTHMICS AND WARFARIN. Dr Nithish Jayakumar ANTI-ARRHYTHMICS AND WARFARIN Dr Nithish Jayakumar Contents 1. Anti-arrhythmics Pacemaker and myocardial potentials Drug classes mechanisms; s/e; contra-indications Management of common arrhythmias 2.

More information

09/05/2018. True/False: All pacemakers have defibrillation capabilities.

09/05/2018. True/False: All pacemakers have defibrillation capabilities. Paul G. Tarasi M.D. Staff Anesthesiologist Allegheny Health Network Adjunct Clinical Assistant Professor of Anesthesiology Temple University School of Medicine Describe different types of implanted cardiac

More information

WARFARIN: PERI OPERATIVE MANAGEMENT

WARFARIN: PERI OPERATIVE MANAGEMENT WARFARIN: PERI OPERATIVE MANAGEMENT OBJECTIVE: To provide an approach to the perioperative management of warfarin treated patients who require an elective or urgent surgery/procedure. To provide an approach

More information

Perioperative Management of Cardiac Implantable Devices

Perioperative Management of Cardiac Implantable Devices Financial Disclosures Breandan Sullivan MD Assistant Professor Co Director Cardiothoracic and Vascular Surgery ICU Department of Anesthesiology and Critical Care Medicine University of Colorado None Perioperative

More information

Dos and Don t in Cardiac Arrhythmia. Case 1 -ECG. Case 1. Management. Emergency Admissions. Reduction of TE risk -CHADS 2 score. Hospital Admissions

Dos and Don t in Cardiac Arrhythmia. Case 1 -ECG. Case 1. Management. Emergency Admissions. Reduction of TE risk -CHADS 2 score. Hospital Admissions Emergency Admissions Dos and Don t in Cardiac Arrhythmia Tom Wong, MD, FESC Consultant Cardiologist, Honorary Senior Lecturer Royal Brompton & Harefield Hospitals National Heart and Lung Institute, Imperial

More information

Atrial Fibrillation Management in the ED. J Fisher May 2014"

Atrial Fibrillation Management in the ED. J Fisher May 2014 Atrial Fibrillation Management in the ED J Fisher May 2014" A 48 yr old man presents with palpitations. He had a big night last night with old mates. ECG How will you manage him? Why important? Common

More information

Joost van Veen Consultant Haematologist

Joost van Veen Consultant Haematologist Joost van Veen Consultant Haematologist Bridging anticoagulation - conclusion Aim Questions What is the evidence? Does oral anticoagulation need to be stopped and if so when? When and at what dose is alternative

More information

Basics of Atrial Fibrillation. By Mini Thannikal NP-BC Mount Sinai St Luke s Hospital New York, NY

Basics of Atrial Fibrillation. By Mini Thannikal NP-BC Mount Sinai St Luke s Hospital New York, NY Basics of Atrial Fibrillation By Mini Thannikal NP-BC Mount Sinai St Luke s Hospital New York, NY Atrial Fibrillation(AF) is a supraventricular tachyarrhythmia characterized by uncoordinated atrial activation

More information

Peri-operative management of pacemakers and implantable cardiac defibrillators

Peri-operative management of pacemakers and implantable cardiac defibrillators Guideline Title: Peri-operative management of patients fitted with Permanent Pacemakers (PPMs) and Implantable Cardioverter Defibrillators (ICDs). Author(s): Jessica Osman (Chief Pacing Physiologist),

More information

9/5/17. Anesthetic considerations for patients with implanted devices for treating chronic pain and more. Objectives:

9/5/17. Anesthetic considerations for patients with implanted devices for treating chronic pain and more. Objectives: Anesthetic considerations for patients with implanted devices for treating chronic pain and more Alaa Abd-Elsayed, MD, MPH Medical Director, UW Pain Services Medical Director, Pain Clinic Section Head,

More information

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39 Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often

More information

Challenges in Anticoagulation and Thromboembolism

Challenges in Anticoagulation and Thromboembolism Challenges in Anticoagulation and Thromboembolism Ethan Cumbler M.D. Assistant Professor of Medicine Hospitalist Medicine Section University of Colorado Denver May 2010 No Conflicts of Interest Objectives

More information

Cardiac Perioperative Risk Assessment American Heart Association Guidelines

Cardiac Perioperative Risk Assessment American Heart Association Guidelines Cardiac Perioperative Risk Assessment American Heart Association Guidelines Dr Gary Liew, MBBS, PhD, FRACP US Board Certified in Cardiovascular CT Executive Committee, Cardiac Institute, Epworth Healthcare

More information

Clinical Practice Committee Anticoagulation Bridging Document

Clinical Practice Committee Anticoagulation Bridging Document Original: 10/23/06 Last Updated: 10/30/07 Clinical Practice Committee Do patients on long term oral anticoagulant therapy who require short term interruption of warfarin for an elective invasive procedure

More information

Professor DA Fitzmaurice Primary Care Clinical Sciences University of Birmingham

Professor DA Fitzmaurice Primary Care Clinical Sciences University of Birmingham New Guidelines for SPAF Professor DA Fitzmaurice Primary Care Clinical Sciences University of Birmingham Stroke prevention and atrial fibrillation Epidemiology of atrial fibrillation How common is it?

More information

Perioperative Management of the Anticoagulated Patient

Perioperative Management of the Anticoagulated Patient Perioperative Management of the Anticoagulated Patient Citywide Resident Perioperative Medical Consultation Conference 5/5/17 Matthew Eisen, MD Director, Anticoagulation Services MetroHealth Medical Center

More information

HEART OF THE MATTER: cardiac issues in safe endoscopy & sedation

HEART OF THE MATTER: cardiac issues in safe endoscopy & sedation HEART OF THE MATTER: cardiac issues in safe endoscopy & sedation YUVAL KONSTANTINO M.D. CARDIOLOGY DEPARTMENT, ELECTROPHYSIOLOGY UNIT, SOROKA MEDICAL CENTER, BEN-GURION UNIVERSITY OUTLINE 1 2 3 Anticoagulation

More information

WARFARIN: PERI-OPERATIVE MANAGEMENT

WARFARIN: PERI-OPERATIVE MANAGEMENT WARFARIN: PERI-OPERATIVE MANAGEMENT OBJECTIVE: To provide an approach to the perioperative management of warfarin-treated patients who require an elective or urgent surgery/procedure. To provide an approach

More information

Periprocedural Anticoagulation Adult Inpatient and Ambulatory Clinical Practice Guideline

Periprocedural Anticoagulation Adult Inpatient and Ambulatory Clinical Practice Guideline Periprocedural Anticoagulation Adult Inpatient and Ambulatory Clinical Practice Guideline A. Scope (disease/condition, treatment, clinical specialty) 1. Adult patients undergoing a procedure or surgery

More information

Treatment strategy decision tree

Treatment strategy decision tree strategy decision tree strategy decision tree Confirmed diagnosis of AF Further investigations and clinical assessment including risk stratification for stroke/thromboembolism Paroxysmal AF Persistent

More information

Management of Anticoagulation during Device Implants; Coumadin to Novel Agents

Management of Anticoagulation during Device Implants; Coumadin to Novel Agents Management of Anticoagulation during Device Implants; Coumadin to Novel Agents DR D Birnie Invited Faculty Core Curriculum Heart Rhythm Society May 8 th 2014 Disclosures Boehringer Ingleheim Research Support

More information

Perioperative Management of Anticoagulation

Perioperative Management of Anticoagulation Perioperative Management of Anticoagulation Presented By: Nibal R. Chamoun, PharmD, BCPS Clinical Assistant Professor, Clinical Coordinator Lebanese American University, School of Pharmacy Presented at:

More information

Update on Palpitations and AF February 28 th 2018

Update on Palpitations and AF February 28 th 2018 Update on Palpitations and AF February 28 th 2018 Dr Mrinal Andrew Saha MA(Cantab) MBBS FRCP PhD Consultant Interventional Cardiologist GHNHSFT Dr Mrinal Saha Appointed 2010 Special interests: Angioplasty,

More information

ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION

ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION Frederick Schaller, DO, MACOI,FACP Adjunct Clinical Professor Touro University Nevada DISCLOSURES I have no financial relationships

More information

Flowchart for ICD patients undergoing Surgery or procedures involving diathermy/magnetic fields

Flowchart for ICD patients undergoing Surgery or procedures involving diathermy/magnetic fields Flowchart for ICD patients undergoing Surgery or procedures involving diathermy/magnetic fields Identify patient with an ICD at POAC. Notify Cardiac Physiologist that patient is due to have surgery and

More information

EnTrust D154VRC Single Chamber ICD 35J delivered 8 seconds BOL, 11.8 seconds ERI 10.7 years**** 35cc, 68g Programmable Active Can

EnTrust D154VRC Single Chamber ICD 35J delivered 8 seconds BOL, 11.8 seconds ERI 10.7 years**** 35cc, 68g Programmable Active Can EnTrust D154ATG Dual Chamber ICD 35J delivered 8 seconds BOL, 11 seconds ERI 7.7 years** 35cc***, 68g Programmable Active Can EnTrust D154VRC Single Chamber ICD 35J delivered 8 seconds BOL, 11.8 seconds

More information

PERIOPERATIVE MANAGEMENT: CARDIAC PACEMAKERS AND DEFIBRILLATORS

PERIOPERATIVE MANAGEMENT: CARDIAC PACEMAKERS AND DEFIBRILLATORS PERIOPERATIVE MANAGEMENT: CARDIAC PACEMAKERS AND DEFIBRILLATORS DR SUSAN CORCORAN CARDIOLOGIST ONCE UPON A TIME.. Single chamber pacemakers Programmed at 70/min VVI 70 UNIPOLAR SYSTEMS A Unipolar Pacing

More information

Question 1: Between 1 July 2014 and 30 June 2015, in the area covered by your CCG:

Question 1: Between 1 July 2014 and 30 June 2015, in the area covered by your CCG: Atrial Fibrillation in Your Area Question 1: Between 1 July 2014 and 30 June 2015, in the area covered by your CCG: a) What was the prevalence of atrial fibrillation (AF)? 6636 (as of 22/10/2015) 2.1%

More information

Atrial fibrillation: current approaches to management

Atrial fibrillation: current approaches to management DRUG REVIEW n Atrial fibrillation: current approaches to management Upasana Tayal MA, MRCP and Robert Greenbaum BSc, MD, FRCP, FESC, FACC Atrial fibrillation is the commonest arrhythmia and GPs have an

More information

Adult Basic Life Support

Adult Basic Life Support Adult Basic Life Support UNRESPONSIVE? Shout for help Open airway NOT BREATHING NORMALLY? Call 112* 30 chest compressions 2 rescue breaths 30 compressions *or national emergency number Fig 1.2_Adult BLS

More information

Current Guideline for AF Treatment. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine

Current Guideline for AF Treatment. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine Current Guideline for AF Treatment Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine Case 1 59 year-old lady Sudden palpitation and breathlessness for 12 hours

More information

Anesthesia for Cardiac Patients for Non Cardiac Surgery. Kimberly Westra DNP, MSN, CRNA

Anesthesia for Cardiac Patients for Non Cardiac Surgery. Kimberly Westra DNP, MSN, CRNA Anesthesia for Cardiac Patients for Non Cardiac Surgery Kimberly Westra DNP, MSN, CRNA Anesthesia for Cardiac Patients for Non Cardiac Surgery Heart Disease is a significant problem in the United States:

More information

Cardiac Electrophysiology

Cardiac Electrophysiology Cardiac Electrophysiology Tamara Langeberg, CNP Minneapolis Heart Institute Cardiac Electrophysiology February 27, 2018 Disclosures None 2 Objectives Rhythm identification Identify indications for cardiac

More information

Challenging Anticoagulation Case Studies. Earl J. Hope, M.D. Tower Health Cardiology

Challenging Anticoagulation Case Studies. Earl J. Hope, M.D. Tower Health Cardiology Challenging Anticoagulation Case Studies Earl J. Hope, M.D. Tower Health Cardiology Financial Disclosures Nothing to disclose Objectives: 1. Understand indications for heparin bridging. 2. Recognize the

More information

DOAC and NOAC are terms for a novel class of directly acting oral anticoagulant drugs including Rivaroxaban, Apixaban, Edoxaban, and Dabigatran.

DOAC and NOAC are terms for a novel class of directly acting oral anticoagulant drugs including Rivaroxaban, Apixaban, Edoxaban, and Dabigatran. Guideline for Patients on Direct Oral Anticoagulant Therapy Requiring Urgent Surgery for Hip Fracture Trust Ref:C10/2017 1. Introduction This guideline is for the clinical management of patients on direct

More information

ESC Stockholm Arrhythmias & pacing

ESC Stockholm Arrhythmias & pacing ESC Stockholm 2010 Take Home Messages for Practitioners Arrhythmias & pacing Prof. Panos E. Vardas Professor of Cardiology Heraklion University Hospital Crete, Greece Disclosures Small teaching fees from

More information

Atrial Fibrillation. A guide for Southwark General Practice. Key Messages. Always work within your knowledge and competency

Atrial Fibrillation. A guide for Southwark General Practice. Key Messages. Always work within your knowledge and competency Atrial Fibrillation A guide for Southwark General Practice Key Messages 1. Routinely offer pulse checks to patients at high risk of AF 2. Use the CHA 2 DS 2 VASc score to identify patients for anticoagulation

More information

Controversies in Atrial Fibrillation and HF

Controversies in Atrial Fibrillation and HF Controversies in Atrial Fibrillation and HF Dr.Yahya Al Hebaishi Cardiac electrophysiology division, PSCC, Riyadh Atrial Fibrillation: Rate or Rhythm? HF and AF: the twin epidemic of cardiovascular disease.

More information

ACTIVITY DISCLAIMER DISCLOSURE. Craig Barstow, MD, FAAFP. Learning Objectives. Associated Session(s) Arrhythmias and Dysrhythmias: PBL

ACTIVITY DISCLAIMER DISCLOSURE. Craig Barstow, MD, FAAFP. Learning Objectives. Associated Session(s) Arrhythmias and Dysrhythmias: PBL ACTIVITY DISCLAIMER Arrhythmias and Dysrhythmias: PBL Craig Barstow, MD, FAAFP The material presented here is being made available by the American Academy of Family Physicians for educational purposes

More information

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018 Atrial Fibrillation and the NOAC s John Raymond MS, PA-C, MHP February 10, 2018 Pathogenesis EPIDEMIOLOGY Arrhythmia-related hospitalisations in the US Ventricular fibrillation 2% Atrial fibrillation 34%

More information

Canadian Cardiovascular Society Atrial Fibrillation Guidelines

Canadian Cardiovascular Society Atrial Fibrillation Guidelines Canadian Cardiovascular Society 2010 Atrial Fibrillation Guidelines Table of Contents Table of Contents... 2 Author Listing... 3 Chapter 2: Atrial Fibrillation: Etiology and Initial Investigations... 6

More information

Gestione peri-operatoria del paziente in terapia con antagonisti della vitamina K. B. Cosmi

Gestione peri-operatoria del paziente in terapia con antagonisti della vitamina K. B. Cosmi Gestione peri-operatoria del paziente in terapia con antagonisti della vitamina K B. Cosmi Department of Angiology and Blood Coagulation S. Orsola-Malpighi University Hospital Bologna, Italy Overview Background

More information

CSI Skills Lab #5: Arrhythmia Interpretation and Treatment

CSI Skills Lab #5: Arrhythmia Interpretation and Treatment CSI 202 - Skills Lab #5: Arrhythmia Interpretation and Treatment Origins of the ACLS Approach: CSI 202 - Skills Lab 5 Notes ACLS training originated in Nebraska in the early 1970 s. Its purpose was to

More information

Atrial Fibrillation Cases. Dr Paul Broadhurst Consultant Cardiologist

Atrial Fibrillation Cases. Dr Paul Broadhurst Consultant Cardiologist Atrial Fibrillation Cases Dr Paul Broadhurst Consultant Cardiologist November 2011 Mr TH age 72 Routine medical for hypertension check Denies any symptoms despite close questioning PMH: hypertension, MI,

More information

Mission Statement for our Arrhythmia Care

Mission Statement for our Arrhythmia Care Mission Statement for our Arrhythmia Care We are dedicated to provide a compassionate and an outstanding care for patients with cardiac arrhythmias. We will be utilizing the cutting edge and the most advanced

More information

CARDIOLOGY EMERGENCIES ON CALL DR. ALI ROOMI CARDIOLOGY ST3 23RD JULY 2016

CARDIOLOGY EMERGENCIES ON CALL DR. ALI ROOMI CARDIOLOGY ST3 23RD JULY 2016 CARDIOLOGY EMERGENCIES ON CALL DR. ALI ROOMI CARDIOLOGY ST3 23RD JULY 2016 + OBJECTIVES Diagnosis and management of ACS When to liaise with tertiary centre Complications of ACS Tachyarrhythmias Bradyarrhythmias

More information

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy Chapter 9 Cardiac Arrhythmias Learning Objectives Define electrical therapy Explain why electrical therapy is preferred initial therapy over drug administration for cardiac arrest and some arrhythmias

More information

EKG Rhythm Interpretation Exam

EKG Rhythm Interpretation Exam as EKG Rhythm Interpretation Exam Name: Date: ID# Unit Assume each strip is a 6 second strip. Passing is 80%. 1. Identify the following rhythm: a. Asystole b. Ventricular fibrillation c. Atrial fibrillation

More information

Atrial fibrillation and flutter in primary care

Atrial fibrillation and flutter in primary care Atrial fibrillation and flutter in primary care Atrial fibrillation is underdiagnosed and undertreated Atrial fibrillation or flutter (AF)* occurs in approximately 1% of the general population. The prevalence

More information

Anticoagulation Therapy and Valve Surgery. Dr Pau Kiew Kong Consultant Cardiothoracic Surgeon

Anticoagulation Therapy and Valve Surgery. Dr Pau Kiew Kong Consultant Cardiothoracic Surgeon Anticoagulation Therapy and Valve Surgery Dr Pau Kiew Kong Consultant Cardiothoracic Surgeon Outline of lecture 1. Type of Valve Surgery 2. Anticoagulation requirements 3. Mechanical (Metallic) prosthetic

More information

Management of Arrhythmias The General Practitioners role

Management of Arrhythmias The General Practitioners role Management of Arrhythmias The General Practitioners role Rohan Gunawardena MD, FRCP, FCCP, FACC Consultant Cardiac Electrophysiologist National Hospital of Sri Lanka Arrhythmias not common Palpitations

More information

» A new drug s trial

» A new drug s trial » A new drug s trial A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause

More information

PATIENT WITH ARRHYTHMIA IN DENTIST S OFFICE. Małgorzata Kurpesa, MD., PhD. Chair&Department of Cardiology

PATIENT WITH ARRHYTHMIA IN DENTIST S OFFICE. Małgorzata Kurpesa, MD., PhD. Chair&Department of Cardiology PATIENT WITH ARRHYTHMIA IN DENTIST S OFFICE Małgorzata Kurpesa, MD., PhD. Chair&Department of Cardiology Medical University of Łódź The heart is made up of four chambers Left Atrium Right Atrium Left Ventricle

More information

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology Atrial Fibrillation: Rate vs. Rhythm Michael Curley, MD Cardiac Electrophysiology I have no relevant financial disclosures pertaining to this topic. A Fib Epidemiology #1 Most common heart rhythm disturbance

More information

NOACS/DOACS*: PERI-OPERATIVE MANAGEMENT

NOACS/DOACS*: PERI-OPERATIVE MANAGEMENT NOACS/DOACS*: PERI-OPERATIVE MANAGEMENT OBJECTIVE: To provide guidance for the peri-operative management of patients who are receiving a newer direct oral anticoagulant (DOAC) and require an elective surgery/procedure.

More information

Challenges in Anticoagulation Bridging and Emerging Therapies. Disclosures and Relationships. Objectives. Dr. Cumbler has no conflicts of interest

Challenges in Anticoagulation Bridging and Emerging Therapies. Disclosures and Relationships. Objectives. Dr. Cumbler has no conflicts of interest Challenges in Anticoagulation Bridging and Emerging Therapies Ethan Cumbler MD FACP Associate Professor of Medicine Hospitalist Medicine Section University of Colorado Denver 2011 Disclosures and Relationships

More information

PRE Operative Care of the High Risk Surgical Patient. Dr A T Dewhurst Consultant Anaesthetist St George s Hospital London

PRE Operative Care of the High Risk Surgical Patient. Dr A T Dewhurst Consultant Anaesthetist St George s Hospital London PRE Operative Care of the High Risk Surgical Patient Dr A T Dewhurst Consultant Anaesthetist St George s Hospital London Perioperative Optimization Shoemaker oxygen delivery goal directed therapy ITS NOT

More information

Pre-operative Assessment. Dr Will Dooley

Pre-operative Assessment. Dr Will Dooley Pre-operative Assessment Dr Will Dooley Plan Assessment structure Investigation options Exam format Why is it important?? Reduce morbidity and mortality Risk management Keep surgeon/anaesthetist happy

More information

SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY

SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY PS1070 SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY TITLE: ADMISSION/DISCHARGE CRITERIA: CARDIOVASCULAR INTENSIVE Job Title of Reviewer: Director, CVICU EFFECTIVE DATE: REVIEWED/REVISED DATE: POLICY

More information

Atrial Fibrillation. Why It s Important. Updated on 2007 / 11 / 23. Microlife Corp ww.microlife.com. Page 1

Atrial Fibrillation. Why It s Important. Updated on 2007 / 11 / 23. Microlife Corp ww.microlife.com. Page 1 Atrial Fibrillation Why It s Important Microlife Corp ww.microlife.com Updated on 2007 / 11 / 23 Page 1 CONTENT ORIGINAL PRESENTATION P3 ~ P13 UPDATED ASH ABSTRACT SUBMISSION INFORMATION INTERESTING LINK

More information

Cost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib

Cost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib Atrial Fibrillation: Guideline Directed Treatment Melissa Wendell, FNP-C, MSN Heart Failure - Lead Nurse Practitioner, Aspirus Wausau Hospital and Aspirus Cardiology Cost and Prevalence of A fib 33.5 million

More information

The most common. hospitalized patients. hypotension due to. filling time Rate control in ICU patients may be difficult as many drugs cause hypotension

The most common. hospitalized patients. hypotension due to. filling time Rate control in ICU patients may be difficult as many drugs cause hypotension Arrhythmias in the critically ill ICU patients: Approach for rapid recognition & management Objectives Be able to identify and manage: Atrial fibrillation with a rapid ventricular response Atrial flutter

More information

Preoperative Evaluation: Patients with Cardiac Disease

Preoperative Evaluation: Patients with Cardiac Disease Advances in Internal Medicine 2012 Preoperative Evaluation: Patients with Cardiac Disease Mary O. Gray, MD Professor of Medicine UC San Francisco Circulation 2007:100:e418-e500 (1) Cardiac Risk Assessment

More information

Atrial Fibrillation Topics for Today. Clinical Controversies Management of Atrial Fibrillation. Atrial Fibrillation in the ER Topics for Today

Atrial Fibrillation Topics for Today. Clinical Controversies Management of Atrial Fibrillation. Atrial Fibrillation in the ER Topics for Today Clinical Controversies Management of Atrial Fibrillation Yerem Yeghiazarians, M.D. Associate Professor of Medicine Leone-Perkins Family Endowed Chair in Cardiology Atrial Fibrillation Topics for Today

More information

CASE IN... Anticoagulation: When to Start,When to Stop. The management of patients who require an. Meet Tracey. Anticoagulation

CASE IN... Anticoagulation: When to Start,When to Stop. The management of patients who require an. Meet Tracey. Anticoagulation Anticoagulation: When to Start,When to Stop Ebtisam Bakhsh, MD; and James D. Douketis, MD, FRCPC Presented at McMaster University s Thrombosis and Hematology Update, October 2006. CASE IN... Anticoagulation

More information

Management of Heart Failure and Cardiomyopathies in Pregnancy

Management of Heart Failure and Cardiomyopathies in Pregnancy Management of Heart Failure and Cardiomyopathies in Pregnancy Professor Sanjay Sharma Disclosures: None Epidemiology of Cardiac Disease In Pregnancy Cardiovascular disease in pregnancy is increasing in

More information

La terapia non anticoagulante nel paziente con FA secondo le Linee Guida F. CONROTTO

La terapia non anticoagulante nel paziente con FA secondo le Linee Guida F. CONROTTO La terapia non anticoagulante nel paziente con FA secondo le Linee Guida F. CONROTTO Rhythm or rate control strategy? N Engl J Med 2002;347:1834 40 Rate Control versus Electrical Cardioversion for Persistent

More information

Chapter (9) Calcium Antagonists

Chapter (9) Calcium Antagonists Chapter (9) Calcium Antagonists (CALCIUM CHANNEL BLOCKERS) Classification Mechanism of Anti-ischemic Actions Indications Drug Interaction with Verapamil Contraindications Adverse Effects Treatment of Drug

More information

t. Recommendations for periprocedural anticoagulation are available lhrough the American College of Chest Physicians Clinical Practice Guidelines.

t. Recommendations for periprocedural anticoagulation are available lhrough the American College of Chest Physicians Clinical Practice Guidelines. Name or Policy: Policy Number: 3364-133-116 Department: Approving Officer: Responsible Agent: cope: x Management of Anticoagulation with Invasive Procedures Pharmacy Chief Operating Officer Director of

More information

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Ventricular Supraventricular VT/VF Primary prevention

More information

Mohammad Zubaid, MB, ChB, FRCPC, FACC

Mohammad Zubaid, MB, ChB, FRCPC, FACC Management and one year outcome of atrial fibrillation in Middle Eastern cohort enrolled in the observational Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) Mohammad Zubaid, MB, ChB, FRCPC, FACC

More information

Atrial Fibrillation is Common. The (S)Low-down on Rapid Afib Resuscitation Step ED Dx - Rx 4/4/2017. There Are 5 Causes of Atrial Fibrillation

Atrial Fibrillation is Common. The (S)Low-down on Rapid Afib Resuscitation Step ED Dx - Rx 4/4/2017. There Are 5 Causes of Atrial Fibrillation The (S)Low-down on Rapid Afib Resuscitation 2017 Corey M. Slovis, M.D. Vanderbilt University Medical Center Metro Nashville Fire Department Nashville International Airport Nashville, TN Atrial Fibrillation

More information

Understanding Atrial Fibrillation Management. Roy Lin, MD

Understanding Atrial Fibrillation Management. Roy Lin, MD Understanding Atrial Fibrillation Management Roy Lin, MD Disclosure None Definition of atrial fibrillation Atrial fibrillation is a supraventricular tachyarrhythmia characterized by uncoordinated atrial

More information

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview Pediatrics Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment See online here The most common form of cardiac arrhythmia in children is sinus tachycardia which can be caused by

More information

Paediatric Cardiac Emergencies - Recognition & Management

Paediatric Cardiac Emergencies - Recognition & Management Paediatric Cardiac Emergencies - Recognition & Management Dr. Leong Ming Chern Paediatric Cardiologist Paediatric & Congenital Heart Centre Amelia 2 month old baby Well at birth Noted to be more dyspnoeic

More information

Valve Disease in the Pregnant Patient

Valve Disease in the Pregnant Patient Valve Disease in the Pregnant Patient Julie B. Damp, MD December 6, 2012 VanderbiltHeart.com If single, do not allow marriage. If fertile, do not allow pregnancy. If pregnant, do not allow delivery. If

More information

Clinical Practice Guideline for Anticoagulation Management

Clinical Practice Guideline for Anticoagulation Management Clinical Practice Guideline for Anticoagulation Management This guideline is to inform practitioners of the Standard of Care for providing safe and effective anticoagulation management for ambulatory patients.

More information

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)

More information

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical Pulmonary embolus - a practical approach to investigation and treatment Sam Janes Wellcome Senior Fellow and Respiratory Physician, University College London Background Diagnosis Treatment Common: 50 cases

More information

VanderbiltEM.com. Atrial Fibrillation Update Don t Miss a Beat ACEP AFib. 20 Facts on Atrial Fibrillation in 20 minutes

VanderbiltEM.com. Atrial Fibrillation Update Don t Miss a Beat ACEP AFib. 20 Facts on Atrial Fibrillation in 20 minutes Atrial Fibrillation Update Don t Miss a Beat ACEP 2015 Corey M. Slovis, M.D. Vanderbilt University Medical Center Metro Nashville Fire Department Nashville International Airport Nashville, TN VanderbiltEM.com

More information

Slide 1: Perioperative Management of Anticoagulation

Slide 1: Perioperative Management of Anticoagulation Perioperative Management of Anticoagulation by Steven L. Cohn, MD, FACP Director, Medical Consultation Service, Kings County Hospital Center, Clinical Professor of Medicine, SUNY Downstate, Brooklyn, NY

More information

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY N.E. Pearce INTRODUCTION Preventable death Cause of morbidity and mortality Risk factors Pulmonary embolism

More information

Debate: New Generation Anti-Coagulation Agents are a Better Choice than Warfarin in the Management of AF

Debate: New Generation Anti-Coagulation Agents are a Better Choice than Warfarin in the Management of AF Debate: New Generation Anti-Coagulation Agents are a Better Choice than Warfarin in the Management of AF Bradley P. Knight, MD Director of Cardiac Electrophysiology Bluhm Cardiovascular Institute Northwestern

More information

State of the Art Management on Atrial Fibrillation in Monica Lo, MD, FACC, FHRS April 15, 2016

State of the Art Management on Atrial Fibrillation in Monica Lo, MD, FACC, FHRS April 15, 2016 State of the Art Management on Atrial Fibrillation in 2016 Monica Lo, MD, FACC, FHRS April 15, 2016 Scope of the Problem More than 30 million people worldwide 1 5 million new cases each year 1 in 4 lifetime

More information

Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014

Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014 Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014 Financial disclosures Consultant Medtronic 3 reasons to evaluate and treat arrhythmias

More information

Aortic Dissection Causes of Death

Aortic Dissection Causes of Death Aortic Dissection Causes of Death Rupture aorta 33.3% Unspecified 33.3% Neurological l deficit it 13.9% Visceral ischemia/kidney failure 11.5% Cardiac tamponade 7.9% (Circulation 2002;105:200-6) Medical

More information

Anti arrhythmic drugs. Hilal Al Saffar College of medicine Baghdad University

Anti arrhythmic drugs. Hilal Al Saffar College of medicine Baghdad University Anti arrhythmic drugs Hilal Al Saffar College of medicine Baghdad University Mechanism of Arrhythmia Abnormal heart pulse formation Abnormal heart pulse conduction Classification of Arrhythmia Abnormal

More information

DVT - initial management NSCCG

DVT - initial management NSCCG Background information Information resources for patients and carers Updates to this care map Synonyms Below knee DVT and bleeding risks Patient with confirmed DVT Scan confirms superficial thrombophlebitis

More information

AF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management

AF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management AF in the ER: Common Scenarios Atrial fibrillation is a common problem with a wide spectrum of presentations. Below are five common emergency room scenarios and the management strategies for each. Evan

More information

AF Today: W. For the majority of patients with atrial. are the Options? Chris Case

AF Today: W. For the majority of patients with atrial. are the Options? Chris Case AF Today: W hat are the Options? Management strategies for patients with atrial fibrillation should depend on the individual patient. Treatment with medications seems adequate for most patients with atrial

More information

Minimally Invasive Stand Alone Cox-Maze Procedure For Patients With Non-Paroxysmal Atrial Fibrillation

Minimally Invasive Stand Alone Cox-Maze Procedure For Patients With Non-Paroxysmal Atrial Fibrillation Minimally Invasive Stand Alone Cox-Maze Procedure For Patients With Non-Paroxysmal Atrial Fibrillation Niv Ad, MD Chief, Cardiac Surgery Inova Heart and Vascular Institute Disclosures Niv Ad: Medtronic

More information

INTERNAL CARDIOVERSION. Lancashire & South Cumbria Cardiac Network

INTERNAL CARDIOVERSION. Lancashire & South Cumbria Cardiac Network INTERNAL CARDIOVERSION Lancashire & South Cumbria Cardiac Network DC Cardioversion AF & AFL safe 1,2 efficacious 3,4 (60-94%) 5 SR - Increases exercise tolerance 6 Maintainence SR unlikely in patients

More information

CVICU EXAM. Mrs. Jennings is a 71-year-old post-op CABG x5 with an IABP in her left femoral artery

CVICU EXAM. Mrs. Jennings is a 71-year-old post-op CABG x5 with an IABP in her left femoral artery CVICU EXAM 1111 North 3rd Street Mrs. Jennings is a 71-year-old post-op CABG x5 with an IABP in her left femoral artery 1. Nursing standards for a patient on an IABP device include: a. Know results of

More information

Preoperative Management of Patients Receiving Antithrombotics

Preoperative Management of Patients Receiving Antithrombotics Preoperative Management of Patients Receiving Antithrombotics Bleeding complications remain an important concern for most surgical procedures. Attempts to minimize the risk of these complications by removing

More information

HTEC 91. Performing ECGs: Procedure. Normal Sinus Rhythm (NSR) Topic for Today: Sinus Rhythms. Characteristics of NSR. Conduction Pathway

HTEC 91. Performing ECGs: Procedure. Normal Sinus Rhythm (NSR) Topic for Today: Sinus Rhythms. Characteristics of NSR. Conduction Pathway HTEC 91 Medical Office Diagnostic Tests Week 3 Performing ECGs: Procedure o ECG protocol: you may NOT do ECG if you have not signed up! If you are signed up and the room is occupied with people who did

More information

The Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician

The Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician The Atrial Fibrillation Clinic in Llanelli Dr Lena Marie Izzat Consultant Cardiovascular Physician Llanelli Multidisciplinary AF Clinic Went live January 2009 Based on the fact that Carmarthenshire has

More information

Case #1. 73 y/o man with h/o HTN and CHF admitted with dizziness and SOB Treated for CHF exacerbation with Lasix Now HR 136

Case #1. 73 y/o man with h/o HTN and CHF admitted with dizziness and SOB Treated for CHF exacerbation with Lasix Now HR 136 Tachycardias Case #1 73 y/o man with h/o HTN and CHF admitted with dizziness and SOB Treated for CHF exacerbation with Lasix Now HR 136 Initial Assessment Check Telemetry screen if pt on tele Telemetry

More information